title: Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
abstract: We studied fecal colonization with vancomycin-resistant enterococci (VRE) in 89 HIV-infected nonhospitalized patients ages 24 to 62 years, including 70 (79%) men (including 41 homosexual and 5 bisexual men) and 19 (21%) women. Of the 89 patients, 61 (69%) were black, 25 (28%) Hispanic, and 3 (3%) white; 53 (60%) had history of ongoing or recent antibacterial therapy with trimethoprim/sulfamethoxazole (29), clarithromycin (18), amoxicillin (7), ofloxacin (3), and metronidazole, doxycycline, dicloxacillin, and cephalexin (1 each). VRE were not isolated from any of the patients studied.
authors.affiliation: Charles R. Drew University of Medicine and Science, Los Angeles, California, USA.
authors.forename: V K
authors.initials: VK
authors.lastname: Dhawan
authors.forename: R
authors.initials: R
authors.lastname: Nachum
authors.forename: N
authors.initials: N
authors.lastname: Bhat
authors.forename: L
authors.initials: L
authors.lastname: Tolbert
authors.forename: M
authors.initials: M
authors.lastname: Agrawal
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001727:Bisexuality; D044383:Black People; D002506:Cephalexin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D004009:Dicloxacillin / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects*; D005243:Feces / Q000382:microbiology; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use*; D044465:White People
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D008795:Metronidazole; D014640:Vancomycin; D000658:Amoxicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D015242:Ofloxacin; D004009:Dicloxacillin; D017291:Clarithromycin; D004318:Doxycycline; D002506:Cephalexin